Amoxicillin-Clavulanate 600-42.9 mg/5 mL Pediatric Dosing
The amoxicillin-clavulanate 600 mg/42.9 mg per 5 mL suspension (14:1 ratio) should be dosed at 90 mg/kg/day of the amoxicillin component, divided into two doses given every 12 hours, with a maximum single dose of 4000 mg amoxicillin. This high-dose formulation is specifically designed for enhanced coverage against resistant pathogens, particularly β-lactamase-producing Haemophilus influenzae and penicillin-resistant Streptococcus pneumoniae 1.
Specific Dosing Parameters
Standard Dosing
- Dose: 90 mg/kg/day (based on amoxicillin component)
- Frequency: Every 12 hours (twice daily)
- Duration: Typically 5-10 days depending on indication 1
- Administration: Can be given with or without food, though absorption of clavulanate is enhanced when taken at the start of a meal 1
Age-Specific Considerations
Infants < 3 months: This formulation is not recommended. Use the 125 mg/31.25 mg per 5 mL suspension at 30 mg/kg/day divided every 12 hours instead 1.
Children ≥ 3 months: The 600-42.9 mg/5 mL formulation is appropriate and provides the 14:1 ratio of amoxicillin to clavulanate, which minimizes gastrointestinal side effects (particularly diarrhea) compared to lower ratio formulations 1.
Children ≥ 40 kg: Should transition to adult tablet dosing rather than suspension 1.
Clinical Indications for High-Dose Formulation
This specific high-dose formulation (90/6.4 mg/kg/day) is indicated for 2, 3, 2, 3:
- β-lactamase-producing Haemophilus influenzae infections (respiratory tract)
- Recurrent or persistent acute otitis media after initial amoxicillin failure
- Moderate to severe infections in children < 2 years
- Recent antibiotic exposure (within 30 days)
- Day care attendance (higher risk of resistant organisms)
- Acute bacterial sinusitis requiring enhanced coverage 4
Evidence-Based Efficacy
The 90/6.4 mg/kg/day regimen demonstrates superior bacteriologic eradication rates 5:
- 98% eradication of S. pneumoniae (including 91% of penicillin-resistant strains with MICs 2-4 μg/mL)
- 94% eradication of H. influenzae
- 89% clinical cure or improvement in children with documented bacterial infections
Recent data from India confirms excellent safety and efficacy, with 82.8% clinical cure rates and only 6.3% experiencing diarrhea 6.
Safety and Tolerability
Common adverse events (generally mild and self-limiting):
- Diarrhea: 6.3-12% (significantly lower with twice-daily vs. three-times-daily dosing) 6, 7
- Gastrointestinal disturbances: Most common adverse effect
- No serious adverse events reported in large pediatric studies 7
Important caveat: This formulation contains aspartame and should NOT be used in phenylketonuric patients 1.
Practical Dosing Example
For a 15 kg child:
- Total daily dose: 15 kg × 90 mg/kg = 1350 mg amoxicillin
- Per dose (every 12 hours): 675 mg amoxicillin
- Volume per dose: 675 mg ÷ 120 mg/mL = 5.6 mL every 12 hours
Critical Distinctions
Do NOT substitute this formulation with other amoxicillin-clavulanate preparations 1:
- The 600-42.9 mg/5 mL (14:1 ratio) is NOT interchangeable with 250-62.5 mg/5 mL (4:1 ratio)
- Two doses of lower-strength formulations do NOT equal one dose of high-dose formulation due to different clavulanate content
- The 14:1 ratio specifically maintains therapeutic amoxicillin levels while minimizing clavulanate-related diarrhea
Special Populations
Renal impairment: Dose adjustment required for severe impairment (GFR < 30 mL/min), though this is rare in pediatrics 1.
Critically ill children post-cardiac surgery: May require 4-hourly dosing due to augmented clearance, unless receiving vasopressors 8.